No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis

OBJECTIVE: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but may be affected by reporting bias. We evalu...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Marcus, Julia L., Glidden, David V., Mayer, Kenneth H., Liu, Albert Y., Buchbinder, Susan P., Amico, K. Rivet, McMahan, Vanessa, Kallas, Esper Georges, Montoya-Herrera, Orlando, Pilotto, Jose, Grant, Robert M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867330/
https://ncbi.nlm.nih.gov/pubmed/24367497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0081997
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky